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ABSTRACT
Hexachlorobenzene (HCB) is a dioxin-type chemical that acts
mainly through the aryl hydrocarbon receptor. Chronic exposure of
rats to HCB increases the activity of malic enzyme (ME). In this
report, we show that this increase is correlated with an induction of
ME messenger RNA (mRNA) levels, with the maximal HCB effect
achieved after 9 days of intoxication. This effect is specific for ME, as
other liver enzymes, such as glyceraldehyde-3-phosphate dehydro-
genase, phosphoenol pyruvate carboxykinase, and mitochondrial
a-glycerol-3-phosphate dehydrogenase, are not affected by HCB. The
induction of ME mRNA levels is accompanied by an increase in ME
promoter activity, as demonstrated by transient transfection exper-
iments performed in rat hepatoma H35 cells. In an attempt to identify
the cis-regulatory elements responsible for the HCB effect, different
promoter deletions and mutations were used. The results obtained
localize the responsive region between positions 2315 and 2177. This
region does not contain either consensus xenobiotic response or ac-
tivating protein-1 elements, the two main mediators of dioxin com-
pounds described to date. In contrast, a thyroid hormone response
element (TRE) is located between 2281 to 2261. Deletions and mu-
tations of the TRE element do not respond to HCB, demonstrating
that this element mediates the response of this dioxin-type compound.
As ME gene expression is regulated mainly by thyroid hormones, we
next investigated the role of T3 receptor (T3R) in the ME gene tran-
scriptional induction mediated by HCB. Using Scatchard analysis, we
show that neither T3R binding features for its ligand nor a1 or b1T3R
mRNA levels are changed with the toxic. In gel shift assays, however,
we observed that protein/DNA complexes formed on TRE from the ME
promoter were induced by HCB. Using an oligonucleotide with a
mutation that eliminates the TRE function, we demonstrate a loss of
the induced protein/DNA complexes. Together, these data suggest
that the dioxin-type compound HCB increases ME gene transcription
by modulating the levels of still unidentified nuclear proteins that
bind to the TRE element of the ME promoter. (Endocrinology 140:
4142–4151, 1999)
HEXACHLOROBENZENE (HCB) is one of the mostwidespread environmental pollutants known. It was
formerly used as a fungicide, and it is currently released as
a product derived from the synthesis of other polyhaloge-
nated compounds (1). Chronic exposure of laboratory ani-
mals to HCB elicits a number of effects, such as triggering
porphyria (2, 3), induction of liver microsomal enzymes (4),
reduced levels of serum T4 (3, 5), reproductive dysfunction
(6, 7), immunosupression (8), and liver and thyroid carcino-
genesis (9, 10). HCB can be classified by its mode of action
as a dioxin-type chemical (11). Almost all of the toxic effects
of this kind of compounds are due to their interaction with
the aryl hydrocarbon receptor (AhR) (12), which has been
described as a ligand-dependent transcription factor that
belongs to the basic-helix-loop-helix superfamily of DNA-
binding proteins. It has been proposed that these compounds
enter into the cell through the plasma membrane and bind
the Ah-receptor complex, consisting of heat shock proteins
(90, 70, and 50), an Src-protein kinase, and AhR (13, 14). After
binding, the AhR leaves the complex and moves into the
nucleus, where it forms a heterodimer with the Ah receptor
nuclear translocator protein (15) and modulates the expres-
sion of genes that have specific xenobiotic- or dioxin-respon-
sive elements (XRE or DRE) in their promoters (16). In ad-
dition, the protein kinase of the AhR complex can initiate a
phosphorylation cascade. In the case of 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD), phosphorylation of epidermal
growth factor receptor, induction of the Ras/mitogen-acti-
vating protein kinase pathway, and activation of the acti-
vating protein-1 (AP-1) complex has been described. This
second pathway does not require any ligand-induced recep-
tor interaction with XRE sequences (17).
Taking into account that dioxin-type chemicals modify the
expression of a number of metabolic genes, it is of interest to
investigate the putative interference between the HCB sig-
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naling pathway and the transcriptional machinery that mod-
ulates the expression of those genes. A previous study has
demonstrated that HCB increases the activity of some thy-
roid-responsive lipogenic enzymes in liver, such as cytosolic
malic enzyme (ME: EC.1.1.1.40), glucose-6-phosphate dehy-
drogenase (EC.1.1.1.49) and 6-phosphogluconate dehydro-
genase (EC.1.1.1.44), with no change in the activity of the mi-
tochondrial a-glycerol-3-phosphate dehydrogenase (aGPD;
EC 1.1.99.5) (18). These researchers have also shown that the
induction of these enzymes was dependent on thyroid hor-
mone (TH) levels.
In this work, we have focused our attention on ME. The
results show that ME messenger RNA (mRNA) levels increase
4-fold in the liver of rats intoxicated for 9 days with HCB. The
compound seems to induce specifically the expression of the
cytosolic ME gene and not other TH-responsive genes, such as
cytosolic glyceraldehyde phosphate dehydrogenase (GAPDH;
EC 1.2.1.12) (19), phosphoenol pyruvate carboxykinase
(PEPCK; EC 4.1.1.32) (20), or mitochondrial aGPD (21). The
effect takes place at the transcription level, as ME promoter
activity increased after its transfection into H35 hepatoma cells
treated with HCB. To understand the molecular mechanisms
involved in the transcriptional control of the ME gene by HCB,
different deletions and mutations of the promoter were used.
The results obtained demonstrate that no consensus xenobiotic
elements (XRE) (16) are present in the ME promoter and that a
construct containing the AP-1 element (22, 23) does not respond
to HCB. Interestingly, we demonstrate that the TH response
element (TRE) located between 2281 to 2261 (24), is the cis-
element responsible for the HCB effect. ME gene expression is
regulated mainly by TH (24) acting through the TRE present in
the ME promoter (25). This fact and the above-mentioned ob-
servation that HCB induces ME activity only in the presence of
TH (18) led us to hypothesize that the TH receptor could be the
putative transcription factor directly affected by HCB and re-
sponsible for ME mRNA induction. HCB could also affect the
receptor binding parameters for its ligand. The results obtained
here indicate that HCB does not induce changes either in T3
receptor (T3R) binding characteristics for its ligand or in a1 or
b1 TH mRNA levels. Using the 2281 to 2261 TRE of the ME
promoter, however, we found a clear induction of protein/
DNA complexes using liver nuclear extracts from rats treated
for 9 days with HCB. Similar results were obtained in H35 cells
treated with 50 nm HCB for 48 h. Competition experiments
demonstrate that the complexes are specific, and by using a
mutated TRE we directly implicate this element in the induction
observed. Although the nature of these nuclear proteins re-
mains to be elucidated, our results describe for the first time the
induction of ME gene transcription by a dioxin-type chemical,
and this effect involves the TRE cis-element of the ME promoter,
but not the a1 or b1 receptor. However, we cannot exclude that
other nuclear receptors and/or associated proteins could be




Female Wistar rats (160–180 g at the start of the experiment) were
maintained in environmental conditions consisting of a 12-h light, 12-h
dark cycle at 22 C. The NIH Guidelines for Human Care and Use of
Laboratory Animals were followed. HCB (1 g/kg BW) was administered
daily through a stomach tube. The fungicide (40 mg/ml) was dissolved
in water containing Tween-20 (0.5 ml/100 ml). Control animals received
equal volumes of the appropriate vehicle (Tween-20). The dose used
elicited clear manifestations of hepatic porphyria, as previously reported
(18). Animals were killed by decapitation; the livers were rapidly re-
moved, immediately frozen in dry ice, and stored at 280 C. HCB for rat
treatment was of commercial grade (95% pure) and was a gift from
Compan˜ı´a Quı´mica S.A. (Buenos Aires, Argentina).
Cell culture
H35 rat hepatoma cells (H4IIE; ATCC CRL 1548, American Type
Culture Collection, Manassas, VA) were cultured in DMEM with 5%
FCS, 5% newborn calf serum, 100 mg/ml streptomycin, 100 IU/ml pen-
icillin, nonessential amino acids, and sodium pyruvate. The HCB used
in cell culture was chemical grade (99% pure; Sigma Chemical Co., St.
Louis, MO); it was dissolved in ethanol and used at a final concentration
of 10 or 50 nm.
Parameters of thyroid function
T4 and T3 levels were measured in hepatic tissue by specific, highly
sensitive RIA as described by Morreale de Escobar et al. (26). In brief,
methanol was added to the still frozen tissue samples and homogenized,
with tracer amounts of [131I]T4 and [
125I]T3 added to each homogenate.
This was followed by the addition of chloroform, in a volume double that
of methanol, centrifugation, and a further extraction of the pellet with
chloroform-methanol (2:1). This extracts more than 90% of the endog-
enous and added iodothyronines. The iodothyronines are then back-
extracted into an aqueous phase and purified by passing this phase
through a Bio-Rad Laboratories, Inc. AG 132 resin columns (Bio-Rad
Laboratories, Inc., Richmond, CA). After performing a pH gradient, the
iodothyronines are eluted with 70% acetic acid, evaporated to dryness,
and dissolved in RIA buffer. Each extract is extensively counted to
determine the recovery of the tracer added to each sample in the initial
homogenate. The samples are subjected to highly sensitive RIAs for the
determination of T4 and T3; the limits of detection are 2.5 pg for T4 and
1.5 pg for T3/tube. Each sample is processed in triplicate at two or more
dilutions.
For Scatchard analysis, liver nuclei were prepared as previously
described (27). The nuclear pellet was resuspended in 5 ml SMT buffer
(0.32 m sucrose, 1 mm MgCl2, and 20 mm Tris, pH 7.8) containing 2 mm
dithiothreitol. The DNA content was determined by the method of
Labarca and Paigen (28). The samples values were interpolated in a
standard curve of absorbance vs. concentration. The maximum binding
capacity and the association constant (Ka) of T3 binding to liver nuclei
were determined by Scatchard plot analysis. Nuclei were incubated in
SMT buffer with increasing concentrations of [125I]T3 ranging from 7.8 3
10211 to 2.5 3 1029 m. A parallel set of tubes was prepared to determine
nonspecific binding as follows. Nuclei were incubated with the same
amount of [125I]T3 plus a saturating nonradioactive T3 concentration
(2.9 3 1027 m). All determinations were performed in duplicate. After
incubation (135 min, 20 C), the nuclei were cooled to O C and centri-
fuged. The nuclear pellet was washed twice in SMCT containing 0.5%
Triton X-100, and bound radioactivity was determined in a g-counter.
Specific binding was calculated by subtracting nonspecific binding from
total binding in each tube.
RNA extraction and Northern blot analysis
Livers from control and treated rats were homogenized in guani-
dinium isothiocyanate, and total RNA was extracted after centrifugation
through a cesium chloride cushion (29). Total RNA from cells was
extracted as described previously (30). Polyadenylated [poly(A)1] RNA
was obtained using the mRNA separator kit (CLONTECH Laboratories,
Inc., Palo Alto, CA). Samples of total RNA or poly(A)1 were electro-
phoresed in 1% agarose gels containing 2.2 m formaldehyde (31), blotted
on Nytran membranes (Schleicher & Schuell, Inc., Keene, NH) and
hybridized using the following rat probes: ME complementary DNA
(cDNA) (32), GAPDH (33), PEPCK (34), aGPD (35), and b-actin (36). The
ME probe was prepared by digesting the plasmid pMEB, which contains
full-length ME cDNA, with BamHI and BglII. The GAPDH insert sub-
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cloned in pGEM plasmid was obtained by digestion with PstI. PEPCK
cDNA subcloned in pPCK10 was obtained after digestion with PstI. The
aGPD insert subcloned in pBluescript IISK was obtained by digestion
with EcoRI. All probes were isolated and labeled by random oligoprim-
ing to a specific activity of 1 3 109 cpm/DNA. When total RNA was
used, the filters were stained with methylene blue to correct for the
amount of applied RNA. In the case of poly(A)1, filters were hybridized
with the b-actin probe. The levels of mRNA were determined by au-
toradiography and quantitated by densitometric scanning. The results
were expressed as an intensity percentage compared with the control
expression of each experiment.
Ribonuclease (RNase) protection assay
A 265-bp XbaI/EcoRI restriction fragment of the c-erbA (37) (TRa1)
probe or the 232-bp PstI-BamHI restriction fragment of the rat T3 receptor
b (38) (TRb1) probe was cloned in the pBS1 SK vector as described
previously (39). 32P-Labeled antisense riboprobes were generated using
T7 RNA polymerase, [a-32P]CTP (800 Ci/mmol; Amersham Pharmacia
Biotech, Aylesbury, UK) and the Riboprobe Transcription Kit (Promega
Corp., Madison, WI) according to the manufacturer’s instructions. As an
internal control to correct for total RNA loading, an additional 28S
ribosomal antisense riboprobe was transcribed from pT7RNA-28S. The
mRNA levels were analyzed by RNase protection with the RPA II assay
kit (RPA II RNase protection assay kit, Ambion, Inc. Austin, TX), es-
sentially as described by the manufacturer. TRa1 and TRb1 (5 3 105
cpm) and 5 3 104 cpm 28S riboprobes were incubated overnight with 20
mg total RNA. After hybridization, samples were digested at 37 C with
a RNase mixture (2.5 U/ml RNase A and 50 U/ml T1 RNase) for 30 min
for TRa1 and 2 h for TRb1 and 28S. The protected fragments were
precipitated and electrophoresed on a denaturing 5% acrylamide gel,
dried, and visualized by autoradiography. The TRa1 and TRb1 mRNA
levels and ribosomal 28S RNA were quantified by densitometric gel
scanning in an Instantimager (Packard, Meridien, CT), and the relative
TRa1 and TRb1 mRNA levels were expressed in arbitrary units after
correction with 28S ribosomal RNA levels.
Transfection assays
59-Deletions of the rat ME promoter [pME 882-chloramphenicol
acetyltransferase (CAT), pME 315-CAT, and pME 177-CAT] (22) and the
mutated constructs, pME 882/DCla-CAT and pME 882/m277-CAT (40),
were used to study ME promoter activity. Point mutagenesis was gen-
erated by Desvergne et al. (40) using the oligonucleotide-directed mu-
tagenesis system (Amersham Pharmacia Biotech) to create ClaI sites at
positions 2260 and 2298 of the ME gene. Oligonucleotides encompass-
ing the ME gene sequences from 2240/2274 and 2285/2315 with
different mutations, extensively described previously (40), were an-
nealed to M13 gene fragment of pME882-CAT. After the synthesis, the
mutated fragment was inserted in the KpnI/PstI site of pUCATSV I (22)
generating pME 882/ClaI-CAT. An internal deletion was then obtained
by ClaI digestion followed by ligation to generate pME-882/DClaI-CAT.
The mutation pME 882/m277-CAT was generated by a point mutation
introduced at 2277 (A3C).
Ten micrograms of each construct were transiently transfected by the
calcium phosphate method (41) together with 2 mg of a plasmid directing
luciferase expression from the cytomegalovirus (CMV) promoter (42) to
correct for transfection efficiency. After transfection, half of the plates
were treated with 50 nm HCB for 48 h, cell extracts were prepared, and
CAT as well as luciferase activities were assayed as previously described
(43, 44).
Preparation of nuclear extracts and gel shift assay
Nuclear extracts were prepared following the method of Gorski et al.
(45) for liver and the method of Andrew and Faller (46) for cells. Proteins
were determined by the Bradford method (47) using the Bio-Rad kit
(Bio-Rad Laboratories, Inc.) with a BSA standard. Gel shift assays were
performed with oligonucleotides labeled with T4 polynucleotide kinase
and [g-32P]ATP and annealed as previously described (48). For binding
reactions, 5 or 10 mg nuclear protein from cells or rat liver, respectively,
were preincubated in a binding reaction mixture containing 40 mm
HEPES (pH 7.9), 200 mm KCl, 0.5 mm dithiothreitol, 0.2 mm EDTA, 5%
Ficoll, and 3 mg poly(dI-dC) for 15 min on ice. In competition experi-
ments, the unlabeled competitor oligonucleotide was added in excess
(100-fold). Then, 50 pg labeled oligonucleotide were added to the mix-
ture and incubated for 30 min at room temperature. The resulting DNA-
protein complexes were separated from free DNA on a 5% polyacryl-
amide gel (29:1, acrylamide-bisacrylamide). Gels were resolved at 20 mA
in a cold room in 0.5 3 TBE (1 3 TBE is 90 mm Tris, 90 mm boric acid,
and 1 mm EDTA, pH 8) before being vacuum dried and exposed to x-ray
film at 270 C.
Statistical analysis
The mRNA levels and the promoter activity results were expressed
as an intensity percentage compared with the control expression of each
experiment. Each value represents the mean 6 sd of three different
experiments. The values from RIA T3 and T4 as well as from the Scat-
chard analysis are the mean 6 sd. Statistical significance between the
control and the different treatments was determined by Student’s t test.
Differences are considered significant at P , 0.05.
Results
Hexachlorobenzene is a potent inductor of ME gene
expression in liver and does not affect other
TH-responsive genes
We first studied whether the reported increase in ME
activity due to HCB (18) correlates with an increase in ME
mRNA levels. Rats were intoxicated daily by gastric intu-
bation with HCB for 9 or 15 days. These intoxication periods
were chosen because ME activity reached 75% of its maxi-
mum value after 9 days of treatment with HCB (18) and were
extended to 15 days when other manifestations of hepatic
intoxication become evident (49). The percentage of ME ac-
tivity is referred to as a maximum determined after 4 weeks
of treatment in previous studies (18). After death, livers were
excised, and total RNA was extracted and analyzed by
Northern blot. Treatment with HCB for 9 days strongly in-
creased ME mRNA levels (4-fold over control values; Fig. 1).
After 15 days of treatment, a 2-fold increase in ME mRNA
compared with the control value was observed. As ME is a
cytosolic lipogenic enzyme mainly regulated by TH (24), we
next investigated whether HCB affected the expression of
other cytosolic thyroid-responsive enzymes involved in dif-
ferent metabolic pathways. We analyzed the HCB effect on
GAPDH, a glucolytic enzyme, and on PEPCK, a key glu-
coneogenetic enzyme. We performed Northern blot analysis
using total RNA from liver of control and intoxicated rats.
HCB did not alter either GAPDH or PEPCK mRNA levels
(Fig. 1).
We also studied the effect of HCB on the mRNA levels of
a mitochondrial TH-responsive enzyme, aGPD. As mRNA
levels of liver aGPD are low, we used poly(A)1 mRNA
instead of total RNA to perform Northern blot analysis. No
changes in aGPD mRNA levels were observed after treat-
ment with HCB (Fig. 1), confirming a previous report that
showed no effect of HCB on aGPD activity (18). Our results
demonstrate that the HCB effect is specific for the ME gene
and that the toxic does not have a generalized action on the
expression of other cytosolic or mitochondrial TH-depen-
dent enzymes.
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HCB stimulates ME promoter activity through the
TRE element
To determine whether the HCB-induced increase in ME
mRNA levels was due to an increase in ME gene transcrip-
tion, we followed a transfection experimental approach us-
ing H35 hepatoma cells. As in rat liver, these cells respond
to HCB by increasing the ME mRNA levels after 48 h of
treatment in a dose-dependent manner (Fig. 2). The construct
pME 882-CAT (23, 40), which contains the full-length ME
promoter (Fig. 3A), was transiently transfected into H35 cells.
Half of the cell plates were then treated for 48 h with 50 nm
HCB, a concentration that showed maximal ME mRNA in-
duction in Northern blot experiments (Fig. 2, line 3). ME
promoter activity was determined by assaying crude cell
extracts for CAT activity, whereas luciferase activity derived
from the cotransfected CMV-Luc was used to correct for
variability in transfection efficiency. The results obtained
demonstrate that HCB increases ME promoter activity 3- to
4-fold (Fig. 3B), indicating that its effect on ME gene expres-
sion takes place at the transcriptional level. To define the
region within the promoter responsible for the HCB re-
sponse, several 59-deletions (23, 40) of the ME promoter (Fig.
3A) were transfected as described above. As shown in Fig. 3B,
the deletion pME-315 responds to HCB as the full promoter
does, whereas no response was found with the deletion pME-
177. This data suggest that cis-acting elements that respond
FIG. 1. Effect of HCB on TH-responsive liver enzyme gene expression. mRNA levels of cytosolic ME, GAPDH, and PEPCK and mitochondrial
aGPD were measured in rat liver after HCB treatment (1 g/kg BW). The pesticide was administered to rats for 9 or 15 days. Total RNA (30
mg) was used to determine ME, GAPDH, and PEPCK transcripts, whereas 5 mg poly(A)1 were used for aGPD mRNA levels. A, Upper panel,
A representative Northern blot of each experimental group. The sizes of the mRNAs are indicated. A, Lower panel, The methylene blue staining
of membranes with total RNA in which the positions of ribosomal RNAs are indicated. Membranes with poly(A)1 were hybridized with b-actin.
B, Quantification of mRNAs, after correction with 28S or b-actin mRNA, by densitometer scanning of autoradiograms from three independent
experiments. The data are the mean 6 SD of three independent experiments. In the case of ME, control levels can be detected and measured
after longer exposures.
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to HCB should be located in a region between 2177 to 2315
of the ME promoter. To identify this cis-regulatory element,
we first analyzed by computer whether any of the previously
described response elements for dioxin-type compounds
(DRE/XRE) were present between 2177 to 2315. No con-
sensus DRE or XRE were found in this region. However, a
previously described functional TRE is located within this
region (from 2261 to 2281) (25). To assess whether the TRE
element is involved in the HCB response, two constructs
containing, respectively, a deletion of the entire TRE
(pME882/DClaI) or a punctual mutation on nucleotide 277
(pME-882/m277) together with the full promoter with an
additional ClaI site (Fig. 3C) were transfected into H35 cells
treated or not with 50 nm HCB. Again, the full promoter with
the ClaI site responds 3- to 4-fold to HCB, as the ClaI mutation
does not modify the activity of the promoter (40). The re-
sponse was totally lost when the TRE element was either
deleted or mutated (Fig. 3D). These data strongly suggest
that the TRE of the ME promoter is involved in the HCB
response.
Moreover, this transfection analysis also demonstrates
that the AP-1 element of the ME promoter (22, 23) located at
2132 bp (Fig. 3A), which has been described to mediate the
dioxin-response in other genes (17), is not involved in the
HCB regulation of ME gene promoter, as the construct pME-
177 that contains this element does not respond to HCB. In
addition, no changes were observed with the toxic in either
the AP-1/DNA complex or the levels of c-Fos and c-Jun
proteins (data not shown).
Parameters of thyroid function in HCB-intoxicated rats
As ME gene transcription is directly controlled by TH (24)
and the levels of serum TH have been described to be altered
in the plasma of HCB-treated rats (18), our next aim was to
determine whether HCB induces ME gene transcription
through the TRE present in the ME promoter. We first an-
alyzed the thyroid status of the intoxicated animals. Previous
data have shown that serum T4 levels are reduced after 9 and
15 days of HCB intoxication, whereas T3 levels are not sig-
nificantly altered (50, 51). Using sensitive RIA assays, we
measured hepatic T4 and T3 levels after HCB treatment. In
contrast with the data on serum TH levels, we found that
hepatic tissue levels of T4 are not affected by the pesticide,
whereas T3 levels are slightly reduced at both times of treat-
ment (Table 1). We next examined whether HCB affects T3
binding affinity for its receptor or induces changes in the
number of sites. Nuclei from control and intoxicated rats
were isolated, and Scatchard plot analysis was performed.
Table 2 shows that neither 9 nor 15 days of HCB treatment
affected the kinetic parameters of T3R.
TR (a1 and b1) mRNA levels are unaltered by
HCB treatment
Most parameters of thyroid status studied to date were
unaltered or showed only very small changes to explain the
increase found in ME gene expression after HCB treatment.
TR is the primary transcription factor that mediates the ac-
tion of TH. There are various isoforms of TRs produced from
two different genes, a and b (52). TRa1 and TRb1 are able to
bind to ME TRE (25). Therefore, another parameter poten-
tially responsible for the increase in ME gene expression is
a change in the expression levels of TRs. We studied the
mRNA levels of TRa1 and TRb1 after HCB treatment. Total
RNA from the livers of each experimental group was iso-
lated, and TRa1 and b1 mRNA levels were determined by
RNase protection assay. The TRa1 probe is 328 nucleotides
(nt) long and contains, in addition to 63 nt of vector se-
quences, 265 nt complementary to TRa1 mRNA (39). The
TRb1 probe is 263 nt long and contains, in addition to 31 nt
of vector sequence, 232 nt complementary to TRb1 (39). A
major 265- or 232-nt-long protected RNA fragment was de-
tected, respectively, for TRa1 or TRb1 in livers of control rats
and in 9- and 15-day HCB-treated rats (Fig. 4, A and B). Other
fragments of smaller size were also detected, presumably
originating from spurious cleavage by RNase. The most
abundant 265- and 232-nt fragments were used in densito-
metric analysis, as we observed that all fragments are iden-
tically regulated. Scanning densitometry of three separate
experiments showed the same levels of TRa1 and TRb1
mRNA in all groups (Fig. 4C), corroborating the lack of HCB
effect observed on T3R concentration by Scatchard analysis
(number of sites; Table 2).
HCB increases protein/DNA complexes formed on TRE
from the ME promoter
As TR (a1 and b1) mRNA levels do not change after HCB
treatment, we determined whether the toxic affects the bind-
ing of other nuclear proteins to the TRE from the ME pro-
moter. We carried out gel shift assays with nuclear extracts
from livers of control and 9- and 15-day HCB-treated rats and
the oligonucleotide (59-GTTGGGGTTAGGGGAGGACAG-
3), corresponding to the TRE element from the ME gene
FIG. 2. HCB increases ME mRNA levels in H35 cells. A representa-
tive Northern blot containing 30 mg total RNA from H35 control cells
or treated for 48 h with 10 or 50 nM HCB and hybridized with the ME
probe (upper) or stained with methylene blue (lower).
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promoter (2281 to 2261; Fig. 5A). Three protein/DNA com-
plexes were found in nuclear extracts of control rat livers
(lane 2), although the two top complexes (1 and 2) were
almost undetectable. Interestingly HCB treatment for 9 days
induced the binding capacity of the three complexes, but this
induction was much more pronounced in the top complexes
1 and 2 (lane 3). Treatment with HCB for 15 days did not
modify the intensity of the complexes compared with that in
control rats. These three complexes are specific, as they are
displaced by a 100-fold excess of unlabeled TRE (lane 5), but
not by an unrelated oligonucleotide (lane 6). Similar results
were obtained when nuclear extracts from control or 50 nm
HCB-treated H35 cells were used (Fig. 5B). To have a more
direct demonstration of the TRE implication, we performed
gel shift assays with a mutated TRE (59-GTTGGGGT-
TAGGGGAGtAaAG9-3). This mutated TRE, in which the
2264 G has been replaced by a T and the 2262 C has been
replaced by an A, virtually eliminates the TRE function, as
demonstrated in transfection experiments by Desvergne et al.
(40). The results obtained using nuclear extracts from livers
of 9-day treated rats (Fig. 5A, lane 7) or from 50 nm HCB-
treated cells (Fig. 5B, lane 4) indicate a loss of binding of all
of the induced hepatic DNA-binding activities. These data
strongly suggest that still unidentified nuclear proteins that
bind to the TRE element of the ME are involved in the
HCB-mediated regulation of this gene.
Discussion
In this paper, we have demonstrated for the first time that
HCB, a dioxin-type chemical, is a potent inductor of ME gene
transcription. These data are in agreement with previous
FIG. 3. HCB effect on ME promoter activity and identification of the HCB responsive region. A and C, Schematic diagram of the full ME promoter
(pME-882), the different deletions (pME-315 and pME-177), and the deleted (pME-882/DClaI) or mutated (pME-882/m277) promoters generated
over the pME-882ClaI construct linked to the CAT reporter gene. Binding sites detected previously are indicated with the corresponding names
of the elements. B and D, ME promoter activity derived from 10 mg of each construct transiently transfected into H35 cells. After transfection,
half of the plates received 50 nM HCB. Forty-eight hours later, the cells were harvested, and CAT and luciferase activities were determined.
The ME promoter activity (CAT/luciferase) is expressed as the fold induction over the control levels (51) of untreated cells. The results are the
mean 6 SD of four independent experiments.
TABLE 1. Influence of HCB on T4 and T3 levels in rat liver
Treatment T4 (ng/g) T3 (ng/g)
Control 33.52 6 4.80 4.00 6 0.30
HCB 9 27.50 6 3.04 2.89 6 0.10a
HCB 15 31.50 6 3.70 3.09 6 0.53a
Results are the mean 6 SD of six values per group.
a Significantly different (P , 0.05) from the control group.
TABLE 2. [125I]T3 binding receptor parameters
Treatment Kd (nM) Bmax (fmol/100 mg DNA)
Control 1.90 6 0.30 3.95 6 0.40
HCB 9 2.00 6 0.30 4.50 6 0.50
HCB 15 1.92 6 0.40 5.10 6 0.60
Results are the mean 6 SD of four values/group.
HEXACHLOROBENZENE AND MALIC ENZYME TRANSCRIPTION 4147
 by on May 11, 2010 endo.endojournals.orgDownloaded from 
work showing that HCB increases the activity of various
TH-responsive lipogenic enzymes in liver (18) and with other
reports that showed the same effect on ME activity for TCDD
(53–55). It has also been shown that HCB, TCDD, and other
related dioxin-type compounds decrease plasma T4 levels
with no change in T3 levels (49, 53–55). However, in the
present study we demonstrate that HCB does not alter T4
levels and only slightly decreases T3 levels when TH are
measured directly in the liver. These differential effects of
HCB on TH could be due to the production of some HCB
metabolites. In this regard, pentachlorophenol, the main
HCB metabolite, competes strongly with T4 for serum carrier
proteins (56). This competition could result in an increase in
free T4 entering the liver. However, preliminary results from
our laboratory indicate that HCB decreases 5-deiodinase ac-
tivity in liver; consequently, less T4 is converted to rT3. In
addition, we observed a decrease in 59-deiodinase, resulting
in less T4/T3 conversion. Whether the effect of HCB on deio-
dinase activity is a direct effect of HCB or is mediated by its
metabolite pentachlorophenol remains to be elucidated.
Based on the above explanation it is unlikely that HCB in-
duces a transient hyperthyroidism in liver. Moreover, the
discrepant response of hepatic mitochondrial and cytosolic
enzymes mRNA levels does not support the hypothesis that
HCB-treated rats are hyperthyroid.
In addition, the results obtained suggest that TH avail-
ability for TH nuclear receptors is not basically affected by
the pesticide. These results are compatible with those re-
ported previously, showing that HCB did not change hepatic
tissue thyroid status (18). We have further shown that HCB
does not modify the number of T3R sites or its ligand binding
affinity, nor are TRa1 or TRb1 mRNA levels affected. The fact
that this compound induces not only ME activity, but also
that of other enzymes of the lipogenic pathway, such as
glucose-6-phosphate dehydrogenase and 6-phosphate dehy-
drogenase (18), suggests that NADPH-generating enzymes
could be specifically affected by HCB. Taking into account
that generation of NADPH enzymes could be involved in
detoxification metabolism, their induction by HCB could be
viewed as a defensive strategy of animals to the aggression
of xenobiotic agents. This is reinforced by the fact that dioxins
and other lipophilic xenobiotics produce a rise in other liver
detoxification enzymes, such as the cytochrome P450 system
(CYP), as well as glucuronyl transferases (57, 58). With re-
spect to the HCB doses used, it is of interest to mention that
the dose assayed elicits in rats a specific effect on the ME
gene, as the toxic does not affect the expression of other
hepatic enzymes, such as the cytosolics GAPDH and PEPCK
or the mitochondrial aGPD. Furthermore, the dose of 50 nm
used in H35 cells is on the order of magnitude of the doses
FIG. 4. TH receptor (TR a1 and b1)
mRNA levels in rat liver in response to
HCB. HCB (1 g/kg BW) was adminis-
tered to rats for 9 or 15 days, and total
liver RNA was extracted. RNase pro-
tection assays showing the 265-nt frag-
ment of TR a1 mRNA (A) or showing in
duplicate the 232-nt fragment of the
TRb1 mRNA (B) are represented. In
both cases, the 115-nt fragment of 28S
ribosomal RNA and the riboprobes with
or without RNase are shown. C, Quan-
tification of mRNAs by densitometric
gel scanning. Each value represents the
mean 6 SD of three independent exper-
iments. For quantification of 28S in the
experiments with TRa1, the gel scan-
ning was measured after less exposure.
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used in most of the studies with compounds whose action is
mediated by the AhR (59, 60).
The data reported in the present work showing that HCB
increases ME promoter activity led us to identify the cis- and
trans-regulatory elements involved in the HCB induction of
ME gene transcription. The study of the mechanism of action
of dioxin-type compounds is becoming increasingly relevant
(12, 13). After its interaction with HCB, AhR trans-locates to
the nucleus, where the AhR-Ah receptor nuclear translocator
heterodimers bind to cis-elements called XRE (16). By com-
puter analyses, no consensus XRE was found in the 882-bp
fragment of the ME promoter studied. As the other mech-
anism of action for dioxin-type compounds is the phosphor-
ylation cascade involving the AP-1 element and c-Fos/c-Jun
proteins (17), we investigated the possible involvement of
this element in the ME regulation mediated by HCB. The fact
that a ME promoter deletion containing the AP-1-binding site
does not respond to HCB suggests that this element is not the
mediator of the induction found. This result together with the
finding of no changes in the levels of AP-1 complexes or in
the c-Fos/c-Jun proteins (not shown) are different from those
reported by Ashida and Matsumura (61), which showed an
increase in the AP-1 complex in response to TCDD as well as
an increase in c-Fos and a decrease in c-Jun levels. These
differences could be due to the fact that these researchers
studied the effect of a different compound (TCDD) in the
liver of another species, the guinea pig. The length and mode
of intoxication are also totally different in the two experi-
mental situations.
Interestingly, the cis-element involved in the HCB regu-
lation of ME promoter is the TRE, as we have extensively
demonstrated in the transfection experiments reported in the
present work. The dioxin-type chemicals increase malic en-
zyme activity only in the presence of TH (18, 53–55), sug-
gesting that this hormone is a permissive factor for the action
of these chemical compounds. ME expression is regulated by
nuclear T3 receptor, and although T3R (a1 and b1) does not
seem to be directly responsible, other transcription factors
interacting with the TRE of ME or with the T3R could be
involved in the mechanism of action of HCB. In this respect,
we found an increase in the protein/TRE-ME complexes
when nuclear extracts were used from rat liver treated for 9
days with HCB. At this time of intoxication, there is an
increase in all of the complexes (1, 2, and 3), although the
major increase was observed in complexes 1 and 2. Similar
results were obtained in H35 cells. The induction observed
in the bottom complex (complex 3) is not constant, suggest-
ing that the main protein/TRE-ME complexes induced in
response to HCB are the top complexes 1 and 2. The nature
of the protein(s) that forms part of these complexes remain
to be elucidated, although they should be related to the TR,
because in a gel shift experiment with a mutated TRE that
does not respond to TH (40), the binding activity of the three
complexes is loss. In addition, preliminary competition ex-
periments using different consensus TREs as competitors
suggest that the proteins induced could be members of the
nuclear hormone receptor superfamily. However, more ex-
periments are required to definitively establish the identity
of such proteins.
T3R, along with receptors for retinoic acid, 9-cis-retinoic
FIG. 5. Effect of HCB on protein/DNA
complexes formed on TRE-ME. A, Nu-
clear extracts (10 mg) from livers of con-
trol rats (C) or rats treated with HCB
for 9 (HCB 9) or 15 days (HCB 15) were
incubated with labeled oligonucleotide
TRE (2281 to 2261 of ME promoter) for
30 min at room temperature. Free and
bound DNA were separated as de-
scribed in Materials and Methods. B,
Electrophoretic mobility shift assay
performed as described in A with 5 mg
nuclear extracts from H35 control (C) or
treated for 48 h with 50 nM HCB. For
competition, nuclear extracts from liv-
ers of rats treated with HCB for 9 days
or from cells treated with 50 nM HCB
were incubated with a 100-fold excess of
unlabeled related (TRE; A, lane 5, or B,
lane 3) or unrelated oligonucleotide (A,
lane 6). To study the involvement of
TRE, a mutated oligonucleotide TRE
mutant 1 (2264 G3T, 2262 C3A)
were incubated with nuclear extracts
from livers of rats treated with HCB for
9 days (A, lane 7) or from H35 cells
treated with HCB for 48 h (B, lane 4).
The protein/DNA complexes are indi-
cated by arrows.
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acid (RXRs), vitamin D, steroid hormone and peroxisome
proliferator activated-receptor (PPAR), belongs to this su-
perfamily of transcription factors (52). T3R binds to TRE as
homodimer or heterodimer with RXR. It has been demon-
strated that the interaction of RXR-T3R with TRE activates
transcription. Taking into account that RXR also forms het-
erodimers with retinoic acid receptor, vitamin D receptor,
PPAR, and orphan receptors, the response of a cell to the TH
depends not only on the levels of TH and T3R, but also on
the relative RXR and other nuclear receptor levels that com-
pete with T3R to bind with RXR. In future studies, it would
be interesting to measure the levels of RXR and other nuclear
receptors after HCB treatment. Another possibility that could
be considered in future studies is whether coactivators or
corepressors of the TRAC family (T3 receptor-associating
cofactors) (52) are affected by HCB.
Finally, the HCB-mediated induction of ME promoter ac-
tivity could also be explained by the fact that this gene is
controlled by the peroxisome proliferator-activated receptor
that binds to an element (PPRE) located at 338 bp (62). Both
AhR and PPAR mediate the induction of different hepatic
CYP isoenzymes by their ligands (63). The induction of ME
by both receptor-ligand systems provides the NADPH re-
quired for the subsequent induction of the CYP activity.
However, the fact that the promoter deletion 2315 that does
not contain the ME-PPRE element still responds to HCB
suggests that this element does not mediate the induction
observed.
In summary, these data confirm that we have identified the
cis-regulatory element that mediates ME gene transcription
in response to HCB. In addition, we found that nuclear pro-
teins bound to this element are induced in response to this
compound. However, the nature of this trans-acting element
still remains to be identified. Future experiments will eluci-
date the participation of other nuclear receptor or associated
proteins in the HCB regulation of ME gene expression.
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